DSIP

DSIP - Delta Sleep-Inducing Peptide Research Compound

DSIP (Delta Sleep-Inducing Peptide) is a nine-amino-acid peptide first isolated in 1977 by Monnier and Schoenenberger from the cerebral venous blood of sleeping rabbits during electrically-induced delta-wave activity. The sequence (Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu) crosses the blood-brain barrier and has been studied in the peptide-research toolkit as the reference “sleep-peptide” - a compound whose research axis is built around delta-wave EEG signaling, sleep architecture, and stress/hormonal regulation.

Why DSIP’s Profile Matters

Most sleep-focused research compounds work through GABAergic or melatonergic pathways. DSIP does not fit either category cleanly. Its published research profile includes delta-wave EEG modulation, GH/LH pulse modulation, stress-hormone (ACTH, cortisol) suppression, and opioid-pathway interactions. That breadth is why DSIP is studied as a neuropeptide rather than as a classical sleep compound - the downstream effects are hormonal and neurophysiological, not sedative.

Research Applications

DSIP is used in studies examining:

• Sleep architecture and delta-wave EEG endpoints
• GH and LH pulsatility under a neuropeptide modulator
• Stress-axis (ACTH, cortisol) suppression models
• Opioid-withdrawal and detoxification research
• Circadian and nocturnal hormone rhythm studies
• Chronic-pain and stress-resilience endpoints

Specifications

Storage & Handling

Unopened vials are kept at 2-8°C under standard cold-chain conditions and remain stable for 12+ months. Reconstitution parameters, solvent compatibility, and post-reconstitution stability for DSIP are documented in the published peer-reviewed literature and standard peptide-chemistry references.

Reference Literature

Published clinical and preclinical DSIP literature is available through PubMed, Google Scholar, and other peer-reviewed databases. WWP does not provide protocol design, dosing guidance, or administration parameters. Those decisions rest with the researcher and any applicable institutional review board.

Common Questions About DSIP Research

What is DSIP peptide used for in research?

It is most commonly studied on the sleep-architecture and neuroendocrine axes. Published work covers delta-wave EEG modulation, GH and LH pulse regulation, ACTH/cortisol suppression, and opioid-pathway crosstalk. It is not a classical sedative - it is a neuropeptide that modulates sleep-phase signaling and hormonal rhythm.

What does DSIP do in research models?

It crosses the blood-brain barrier and binds central-nervous-system targets that are not yet fully characterized. Downstream effects in published studies include deeper delta-wave activity, suppressed stress-axis signaling, and modulated pituitary-hormone pulsatility.

How does DSIP compare to other sleep peptides?

DSIP is often grouped with melatonergic, GABAergic, and orexinergic sleep compounds, but it acts through a distinct and not-fully-mapped pathway. Research designs often pair DSIP with other peptides because its mechanism does not overlap with the standard sleep-pharmacology classes.

Is DSIP FDA approved?

No. DSIP is not FDA approved for any use. It is a research compound only. Every vial WWP ships is labeled and sold strictly for laboratory and research use only.

How is DSIP stored?

Unopened vials are stored at 2-8°C and stay stable for 12+ months. Once reconstituted with bacteriostatic water, the solution is kept at 2-8°C and used within 28-30 days.

Purity Guarantee

Every batch is ≥99% purity. Send us a COA from any independent test and we’ll issue store credit regardless of what it shows.